Understanding Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterised by inflammation and ulceration of the colonic mucosa. Unlike Crohn's disease, which can affect any part of the GI tract, UC is confined to the colon and rectum, with inflammation extending continuously from the rectum proximally.

Conventional treatment — 5-aminosalicylates, corticosteroids, immunomodulators, and biologic therapies — remains the cornerstone of UC management. Functional medicine does not replace these treatments, especially during active flares. Rather, it complements conventional care by addressing the environmental and lifestyle factors that influence disease activity, flare frequency, and mucosal healing.

Important: Ulcerative colitis is a serious medical condition that requires ongoing gastroenterological care. The approaches discussed here are complementary to, not replacements for, evidence-based medical treatment.

The Functional Medicine Perspective on UC

While conventional medicine focuses on suppressing the overactive immune response, functional medicine asks additional questions:

  • What is driving the immune dysregulation in this individual?
  • Which environmental triggers are contributing to flare frequency?
  • How can we support mucosal healing and extend remission periods?
  • What role does the microbiome play in this patient's disease activity?

Dietary Approaches With Evidence in UC

The Specific Carbohydrate Diet (SCD)

The SCD removes complex carbohydrates, refined sugars, and most grains on the theory that unabsorbed carbohydrates fuel pathogenic bacterial overgrowth in the colon. A 2020 study in the Journal of Clinical Gastroenterology found that UC patients following the SCD for 12 weeks showed significant improvements in clinical symptoms and a reduction in faecal calprotectin (an objective marker of intestinal inflammation).

The Mediterranean Diet

Rich in omega-3 fatty acids, polyphenols, and diverse plant fibres, the Mediterranean diet has been associated with reduced relapse rates in UC patients in observational studies. Its anti-inflammatory profile — high in olive oil, fatty fish, vegetables, and fermented foods — addresses multiple inflammatory pathways simultaneously.

The IBD-AID (Anti-Inflammatory Diet)

Developed at the University of Massachusetts, the IBD-AID is a phased diet that gradually introduces prebiotics and probiotics while avoiding refined carbohydrates and certain fats. A pilot study showed 61% of participants achieved clinical remission on the IBD-AID within 4 weeks.

Key Nutrients for Mucosal Healing

Butyrate

Butyrate is the primary energy source for colonocytes (the cells lining the colon). UC patients consistently show reduced butyrate-producing bacteria and lower faecal butyrate levels. Supporting butyrate production through soluble fibre intake (oats, cooked and cooled potatoes, psyllium) or direct butyrate supplementation may support mucosal healing during remission.

Curcumin

Curcumin supplementation has been studied as an adjunct therapy in UC with promising results. A 2020 meta-analysis found that curcumin combined with 5-ASA therapy was significantly more effective at inducing and maintaining remission than 5-ASA alone. Typical doses in studies range from 1-3g daily.

Omega-3 Fatty Acids

EPA and DHA from fish oil are converted into resolvins and protectins that actively resolve inflammation. While study results have been mixed, a 2023 meta-analysis found that high-dose fish oil supplementation (2-4g EPA+DHA daily) reduced relapse rates in UC patients in remission.

Vitamin D

Vitamin D deficiency is common in UC patients and is associated with increased disease activity and higher relapse rates. Maintaining serum 25(OH)D levels above 40 ng/mL has been associated with reduced flare frequency in observational studies. Regular monitoring and supplementation as needed is recommended.

Microbiome-Targeted Strategies

UC is characterised by reduced microbial diversity and specific compositional shifts. Functional approaches to restoring a healthier microbiome include:

  • Diverse plant fibre (during remission) — the "30 plants per week" target supports microbial diversity; during active flares, fibre may need to be reduced and reintroduced gradually during remission
  • Specific probiotics — VSL#3 (now Visbiome) is the most studied probiotic in UC and has evidence for maintaining remission in mild-to-moderate disease
  • Faecal microbiota transplantation (FMT) — emerging evidence shows FMT can induce remission in some UC patients, though it is not yet standard of care outside clinical trials

Lifestyle Factors That Influence Flares

  • Stress management — psychological stress is one of the most consistent triggers for UC flares. Mindfulness-based stress reduction and gut-directed hypnotherapy have evidence for reducing flare frequency
  • Sleep quality — poor sleep increases inflammatory cytokines and is associated with higher UC disease activity scores
  • NSAIDs avoidance — ibuprofen, naproxen, and other NSAIDs can trigger UC flares and should be avoided; paracetamol (acetaminophen) is a safer alternative for pain relief
  • Moderate exercise — regular, moderate-intensity exercise reduces systemic inflammation and has been associated with longer remission periods in UC

GutIQ provides a comprehensive assessment that can help UC patients identify potential trigger patterns and track symptom changes over time, supporting more informed conversations with their gastroenterology team.